Nanocan Therapeutics
Nanocan Therapeutics is a startup headquartered in National Harbor, United States, founded in 2020. It has raised at least $5.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Nanocan Therapeutics has raised at least $5.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Nanocan Therapeutics sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Related
Questions and answers
What does Nanocan Therapeutics do?
Nanocan Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Nanocan Therapeutics raised?
At least $5.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Nanocan Therapeutics based?
Nanocan Therapeutics is headquartered in National Harbor, United States.
When was Nanocan Therapeutics founded?
Nanocan Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.